Primary central nervous system lymphoma imaged with FDG-PET/CT

被引：0
|
作者：
Marti Samper, Alejandro [1 ]
机构：
[1] Inst Nacl Cancerol, Grp Med Nucl PET, Bogota, Colombia
来源：
REVISTA COLOMBIANA DE CANCEROLOGIA | 2013年 / 17卷 / 03期
关键词：
Positron emission tomography; Primary central nervous system lymphoma; Staging;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Primary central nervous system lymphoma (PCNSL) is now known as a form of non-Hodgkin extranodal high-grade B-cell, usually diffuse large B cell, originating in the brain, leptomeninges, spinal cord or eyes, and usually remains confined to the central nervous system (CNS). The main risk factor is immunodeficiency. It represents 4% of primary CNS tumors, with an incidence rate adjusted for age of 4/1,000,000/year. Positron emission tomography (PET) has shown to have an impact on staging impact patients with diffuse large B cell lymphoma, but there is limited experience in cases of primary CNS involvement. (C) 2013 Instituto Nacional de Cancerologia. Published by Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码：126 / 129
页数：4
相关论文
共 50 条
  • [41] Is ceCT necessary beyond FDG-PET/CT for primary staging in Hodgkin lymphoma?
    Kornelia, Kajary
    Zsuzsa, Molnar
    Szabolcs, Szakall, Jr.
    Peter, Molnar
    Zsolt, Lengyel
    ORVOSI HETILAP, 2014, 155 (06) : 226 - 230
  • [42] Use of 18F-FDG PET/CT in initial assessment of primary central nervous system lymphoma in immunocompetent patients
    Bertaux, M.
    Edeline, V.
    Bera, G.
    Hobert, M. -O.
    Houillier, C.
    Soussain, C.
    Xuan, K. H.
    Kas, A.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2016, 40 (02): : 103 - 113
  • [43] Clinical Utility of Baseline 18-F-FDG-PET/CT in Prognostication of Patients with Primary Central Nervous System Lymphoma
    Gupta, M., Sr.
    Purandare, N.
    Rangarajan, V.
    Menon, H.
    Moiyadi, A.
    Shetty, P.
    Epari, S.
    Laskar, S.
    Goda, J.
    Jalali, R.
    Gupta, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S179 - S180
  • [44] FDG-PET in lymphoma of the liver: Lesion detection by FDG-PET vs. CT.
    Varavithya, V
    Phongkitkarun, S
    Kazama, T
    Faria, SC
    Mar, M
    Podoloff, DA
    Macapinlac, HA
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 83P - 83P
  • [45] Usefulness of FDG-PET in monitoring therapeutic effects on a central nervous system malignant lymphoma: Report of three cases
    Masada, T
    Matsumoto, Y
    Kawai, N
    Tamiya, T
    Nagao, S
    NEUROLOGICAL SURGERY, 2004, 32 (08): : 859 - 864
  • [46] NERVOUS SYSTEM INVOLVEMENT BY RECURRENCE OF NON-HODGKIN LYMPHOMA ON FDG-PET/CT: LEPTOMENINGEAL DISEASE AND NEUROLYMPHOMATOSIS
    Iravani, A.
    Bui, C.
    Shen, L.
    Mansberg, R.
    INTERNAL MEDICINE JOURNAL, 2015, 45 : 22 - 23
  • [47] FDG-PET/CT in Primary Staging of Cholangiocarcinoma
    Sabate-Llobera, A.
    Gracia-Sanchez, L.
    Mestres-Marti, J.
    Puig-Povedano, I.
    Vercher-Conejero, J. L.
    Llinares-Tello, E.
    Rodriguez-Bel, L.
    Robles-Barba, J. J.
    Cortes-Romera, M.
    Llado-Garriga, L.
    Serrano-Pinol, T.
    Ramos-Rubio, E.
    Gamez-Cenzano, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S16 - S17
  • [48] FDG-PET in lymphoma
    Michel Meignan
    Cancer Imaging, 14 (Suppl 1)
  • [49] FDG-PET in patients with paraneoplastic syndrome of the central and peripheral nervous system.
    Richter, M
    Munz, DL
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 256P - 256P
  • [50] Primary Central Nervous System Lymphoma: Lessons and Opportunities from 2 Decades of CT and PET/CT
    Jara, Hernan
    RADIOLOGY, 2019, 292 (02) : 447 - 448
12345